DrKumo Leadership

DrKumo Leadership Team consists of serial entrepreneurs with proven track records of successful exits in the high-tech and health care industries.

We are a diverse team of healthcare and technology professionals who integrate mobile-enabled wireless IoMT (Internet of Medical Things), cloud service, and Artificial Intelligence/Machine Learning (AI/ML) technology.

We know that health and wellness are a continuous engagement among all members of the health ecosystem— patients, healthcare providers, and health insurers both public and private, with the patient being the center of care.

With the advances in IoMT, we envision that patients can receive continuous care—anytime and anywhere, for a better quality of life, without being confined to traditional clinical environment.

Dr. Kelly Nguyen, Pharm.D., DrKumo CEO/Co-Founder

Dr. Kelly Nguyen, Pharm.D.

Co-Founder / CEO

As the co-founder and CEO of DrKumo, Dr. Kelly Nguyen is at the forefront of revolutionizing healthcare through technology. Under her leadership, DrKumo has earned recognition as one of four distinguished companies awarded the U.S. Department of Veterans Affairs’ (VA) $1.032 billion national contract for an eight-year period, providing Remote Patient Monitoring-Home Telehealth (RPM-HT) technology solutions. Dr. Nguyen’s relentless commitment has been the key to unlocking the potential of advanced technologies in Remote Patient Monitoring, Artificial Intelligence, and Machine Learning, dramatically transforming healthcare delivery and elevating patient outcomes to new heights.

As a co-founder of Mission Road Pharmacy, she pioneered and consistently pushed the boundaries of what’s possible in Specialty Pharmacy, focusing on serving patients in critical areas such as oncology, HIV/AIDS, hepatitis, rheumatoid arthritis, and mental health therapies. Her strategic vision fueled the company’s exponential growth, with a 200% increase in revenue, reaching $160M within six years. This growth led to the acquisition and subsequent integration of the company into United Health/OptumRx, showcasing Dr. Nguyen’s exceptional business acumen and her dedication to enhancing patient care. Her inventive spirit is further evidenced by her patents in Cryptographic Identity Authentication, blockchain, and a secure, anti-counterfeiting track and trace system, with 2 patents granted and 4 pending in the field of cryptographic security and advance AI/ML for autonomous, close-loop healthcare monitoring and proactive intervention system.

For her impact-driven and unwavering commitment of enhancing healthcare quality and accessibility through state-of-the art technology, Dr. Nguyen was awarded with the prestigious North America 2020 Cartier Women’s Initiative (CWI) Fellowship and was recognized by the Alumni Association of University of California San Francisco (AAUCSF) with the distinguished 2024 UCSF Alumni Achievement Award, Alumni Entrepreneur Award. This award honors an alum who demonstrates the highest caliber of innovation in science and/or health care through risk-taking actions and value-creating transformations.


Duc Pham

Cofounder / President & CTO

Pham is an entrepreneur and thought leader in the blockchain, cryptography/data encryption and cybersecurity space for more than 20 years. Prior to DrKumo, he was the founder and CTO of Vormetric (acquired by Thales for $400 million in 2015), a leader in information security company. Under his leadership, the Vormetric engineering team developed the most advanced enterprise-class, cross-platform information security protection system that can protect the data core even when the whole network and several other system components are compromised. Thanks to the architecture and unique inventions, Vormetric became the leader in enterprise information security technology, integrating encryption, access control, audit, and host integrity protection to provide a secure computing environment for high-profile clients in the financial and banking sectors as well as the US federal government. 

Pham also led and won major OEM agreements with IBM (Database Encryption Expert) and Symantec (Media Server Encryption Option). Prior to Vormetric, Pham was the founder and CEO of Linux4 Networks, a leader in SSL encryption acceleration technology (acquired by Avaya in 2001), which achieved 160 times performance of a high-end CPU with a single cryptographic accelerator module, resulting in a humongous 16,000% TCO (Total Cost of Ownership) savings in system management, software licensing, power, hardware, network infrastructure, etc.

Pham has extensive experience in corporate strategy with proven track record for product development, blockchain, data security operations, enterprise software, electronic payment networks, mission-critical storage systems, and consumer and mobile computing. He invented the Vormetric data encryption technology.
Pham has 11 granted and 20 pending patents in the field of Telehealth/Digital Health, Blockchain, Cybersecurity/Data Encryption, Securing Messaging, Parallel Processing, Consumer/Mobile Computing, and Loyalty systems.

Steven Phung, DrKumo, Cofounder

Steven Phung

VP Business Development

Prior to DrKumo, Mr. Phung was the Director of Information Technology of Los Angeles County where he managed an IT Department of 260 staff members that supports an organization of 14,000 people at multiple locations and overseeing the entire technology infrastructure and decision making; managed a data center and network infrastructure assets in support of enterprise business applications (HIT) Health Information Technology systems that meet the security scrutiny from HIPAA and Federal standards for the Medical and Educational Entities; developed IT Policies and standardized IT procedures and protocols that exceeds the California State Audit Standards.

James McBride, Enterprise Systems

James McBride

Enterprise Systems

Mr. James McBride is a Veteran U.S. Marine Corps Lieutenant Colonel with over 25 years of National Security; Naval Aviation; Logistics; Curriculum Development; and Command, Control, Communications, Computers, & Intelligence (C4I) systems integration expertise.

Enlisting in 1992, and receiving an officer commission in 1997, Mr. McBride crewed on helicopters, navigated electronic warfare aircraft over Iraq, served with the infantry in Afghanistan, and led many Marines and civilians in dynamic environments in the air, on land, and at sea through seven deployments overseas.  He has a long history of tangible success in team building, organizational development, and successful oversight of the integration of a myriad of complex C4I networks in austere (no infrastructure) and immoderate environments.

Versed in Project Management and Scrum/Agile Methodologies, Mr. McBride led multiple successful cross-functional teams of Data, Systems, and Information Technology (IT) Administration professionals.  Later in his career, Mr. McBride was a senior executive of over 600 personnel and accountable for $14M worth of equipment, where he was awarded for exceptional communication skills, innovating and developing new C4I capabilities and tactics, and enhancing logistics efficiency.  His last tour of active duty was as a lead Joint Staff strategic planner for a global simulation exercise that synchronized the communication and collaboration of all eleven U.S. combatant commands around the world.

Dr David Sulkin MD, The Ninth Secretary of the US Department of Veterans Affairs

Dr. David J. Shulkin, M.D.

The Ninth Secretary of the U.S. Department of Veterans Affairs

The Honorable David J. Shulkin, a board-certified internist and a fellow of the American College of Physicians, is a prominent figure in American healthcare. He served as the 9th Secretary of Veterans Affairs (VA) and was the VA’s Under Secretary for Health, managing the largest integrated health care system in the U.S.

Dr. Shulkin held chief executive roles at Morristown Medical Center and Beth Israel Medical Center, and leadership positions at University of Pennsylvania Health System and Temple University Hospital. Acknowledged as one of the “50 Most Influential Physician Executives” by Modern Healthcare, he also features among the “One Hundred Most Influential People in American Healthcare”.

dr richard carmona 17th surgeon general united states

Dr. Richard H. Carmona, M.D.

17th Surgeon General of the United States

Dr. Richard H. Carmona, the 17th Surgeon General of the United States and Distinguished Laureate Professor at the University of Arizona, has made significant contributions to medicine, public health, and service. From his valorous days as a combat-decorated Vietnam War veteran with the U.S. Army Special Forces to his groundbreaking work in the health sector, his journey is remarkable.

A top graduate from the University of California, San Francisco, he further honed his expertise with a master’s degree in public health from the University of Arizona. Not just limited to medicine, Dr. Carmona’s leadership shone as a Deputy Sheriff, specializing in SWAT operations. As Surgeon General, he championed transformative health initiatives, notably his influential report on the dangers of secondhand smoke.

His enduring passion for public health continues to inspire, evident in his significant role in the Covid-19 response at the University of Arizona. Dr. Carmona’s legacy is one of relentless commitment, leadership, and transformative impact.


Robert C. Boullon

CEO, Argus Medical Management

Mr. Boullon has been with Argus Medical Management since its inception in 1995, serving in various leadership roles including Acting Administrator, COO, and CEO. His background includes working in healthcare finance at several hospitals in Los Angeles and Orange County. Mr. Boullon has also taught healthcare finance at universities in Southern California and served as President of the HealthCare Financial Management Association of Southern California. He holds degrees from UCLA and U.C. Irvine.


Bill Schroeder


Mr. Bill Schroeder, or Mr. William J Schroeder, a highly regarded technology industry executive and sought after advisory member in Silicon Valley and beyond. His substantial experience building and taking companies public makes him a valuable addition as we take IDLogiq to the next level of development.

Mr. Schroeder has grown tech companies from start-up through IPO and led three large successful IPO’s (Diamond Multimedia, Conner Peripherals, and Priam). He has served as the president and/or CEO of high tech companies in Silicon Valley, also served on the boards of those companies, as well as an outside board member with several other companies.

He helped guide several companies to successful IPOs and acquisitions, including Nimble Storage (IPO 2013 with $1.5B valuation, acquired by HP) , Con-way (acquired by XPO Logistics for $3B), Vormetric (acquired by Thales Group for $400M), Oxford Semiconductor (acquired by PLX Technology), WatchGuard Technologies (IPO, acquired by Francisco Partners), AlphaSmart (IPO, acquired by Renaissance Learning), Omneon (acquired by Harmonic) , Xircom (IPO, acquired by Intel for $748M), and VXtreme (acquired by Microsoft).

Prior to working in Silicon Valley, Mr. Schroeder worked for McKinsey & Company as a consultant. He holds the BSEE and MSEE from Marquette University and the MBA with High Distinction from Harvard Business School.


Dr. Jack Bui, MD/PhD


Dr. Jack Bui, MD/PhD, is board-certified in Clinical Pathology and serves as Director of the UCSD Stem Cell Processing Laboratory and Flow Cytometry and Immunology Laboratory.  His core research interest is in understanding immune recognition of uninfected, stress or damaged tissues, such as tumor cells and transplantable normal cells. His basic research uses both mouse models of cancer and samples from cancer patients. He has expertise in the immunophenotyping of immune subsets and in particular participates in multiple clinical trials where patient samples are analyzed for immune cell numbers and activity.

Dr. Bui received his PhD in 1999 working on T cell memory at UCSD in Steve Hedrick’s Lab.  He received his MD in 2001 at UCSD and then entered a research residency program at Washington University.  He worked with Robert Schreiber studying how innate cells and T-regulatory cells influence tumor formation.


Dr. Jeffrey Glenn, MD/PhD


Dr. Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering. He also heads a research laboratory focused on studying molecular virology and the translation of that knowledge into novel antiviral strategies, as well as the development of new treatments for liver diseases and cancer. He is the founder of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), co-founder of Riboscience LLC, and founder of I-Cubed Therapeutics, biotechnology companies developing several new classes of antiviral and anti-cancer drugs.

Dr. Glenn was born in Los Angeles, and grew up in Switzerland. He received his B.A. degree in Biochemistry and French Civilization from U.C. Berkeley from where he graduated summa cum laude. He received his M.D. and Ph.D. in Biochemistry and Biophysics from U.C.S.F.. He trained in internal medicine at Stanford University where he completed specialty training in gastroenterology, and joined the faculty in 2000.

He is the principal investigator on multiple NIH grants, an inventor on numerous patents, an elected member of the American Society for Clinical Investigation, and a member of the FDA Antiviral Drugs Advisory Committee.


Dr. David Masiello, MD


Dr. David Masiello is a Hematology Oncology Specialist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Community Memorial Hospital, Desert Regional Medical Center, Foothill Presbyterian Hospital, Keck Medical Center Of USC, San Dimas Community Hospital, St John’s Regional Medical Center, White Memorial Medical Center and White Memorial Medical Center.

Dr. Masiello received his Bachelors of Science in Biochemistry and Molecular Biology from the University of Chicago. He attended medical school at Boston University School of medicine.  After medical school, he completed his internship year and residency in internal medicine at the Boston City Hospital. 

He then moved to Los Angeles completing a fellowship in Hematology/Oncology at University of Southern California/LAC+USC.  Trained in oncologic and hematologic malignancies as well as hematological disorders, Dr. Masiello shares a special interest in leukemia.


Kazufuku Nitta


Mr. Kazufuku Nitta is an inventor and pioneer in medical High Frequency Oscillatory (HFO) ventilation market. He is the founder of Metran Co., Ltd. and invented the first HFO ventilator for premature neonates in 1984. He has been at the forefront of ventilatory technology by developing new and unique products that meet the various clinical needs of customers worldwide. As a result of his leadership and personal involvement in research and development for over 30 years, Metran have successfully launched multiple easy-to-use products with very sophisticated functions using unique technology and became the leader in HFO market with the very best of Japanese technology and quality to deliver products that people can trust.

Thanks to his inventions, High Frequency Oscillatory ventilators have helped save thousands of lives of premature babies or patients recovering from life-threatening situations, and for that great cause, his company received an Honorable Imperial Visit by The Emperor of Japan. He hopes to continue to put the needs of children, their parents and loved ones first and to continue to deliver these products throughout the world.

MK Tribbie, Advisor, DrKumo Inc.

MK Tribbie


Mr. MK Tribbie has over 20 years’ experience developing and fielding advanced concept technology prototyping & solutions for DOD and DHS customers that address their critical operational gaps and shortfalls and 21 years’ experience as fully mission-qualified Naval Aviator and leader. He has extensive experience assisting Department of Defense (DOD) Defense, Department of Homeland Security (DHS). He is an experienced high-visibility/high-expectation event coordinator in development of thought-provoking technical exchange meetings and events for United States Customs and Border Protection (CBP), Office of Acquisition, Assistant Commissioner, Executives and senior staff. For DOD, he has assembled, coordinated and presented the output of subject matter expert (SME) panels and provided courses of action to inform leadership on achievable way-ahead alternatives.

Some of the Notable Awards/Certifications include receiving the prestigious Naval War College, James V. Forrestal Award for staff-organized, time-constrained, high-visibility Force Planning exercise, formulating a threat-based, tangible alternative National Military Strategy and force structure. DHS PM-Level III, Senior Level Certification.

independence day 2023
happy flag day 2023
On this Flag Day, we salute the spirit of our great nation! 🎉 As we embrace unity and freedom, let us honor the symbol that represents our shared values. Happy Flag Day! 🎆✨ #FlagDay #ProudAmerican #DrKumo #RemotePatientMonitoring
remembering d-day 2023
memorial day 2023

Memorial Day: A Day of Gratitude and Honor
Today, we pause to remember and express our heartfelt gratitude to our Veterans. Their service to our nation is beyond compare, and their loved ones’ sacrifices are immeasurable. We recall the words of Ronald Reagan, “Their lives remind us that freedom is not bought cheaply. It has a cost; it imposes a burden.” We take immense pride in having the privilege of serving you, and on this day, we salute you. Thank you, Veterans, and their families for your service and sacrifices.

Free Initial Consultation

Get a free 30-45 minutes consultation with one of our DrKumo RPM experts to learn everything you need to know about Remote Patient Monitoring and how you can make your RPM program successful.

To start please fill out the form and we will get in touch with you shortly.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.